Loading...

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances

Introduction: Acute lymphoblastic leukemia (ALL) is the first neoplasm where the assessment of early response to therapy by minimal residual disease (MRD) monitoring has proven to be a fundamental tool to guide therapeutic choices. The most standardized methods to study MRD in ALL are multi-parametr...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Oncol
Main Authors: Della Starza, Irene, Chiaretti, Sabina, De Propris, Maria S., Elia, Loredana, Cavalli, Marzia, De Novi, Lucia A., Soscia, Roberta, Messina, Monica, Vitale, Antonella, Guarini, Anna, Foà, Robin
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6692455/
https://ncbi.nlm.nih.gov/pubmed/31448230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00726
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!